FOLH1 and neoplasm: Notably, we could demonstrate this prognostic value at an even earlier therapy stage (6 weeks) with quantitative SPECT/CT without the need for an additional PET/CT scan and previous work showed high and comparable repeatability of tumor volumetry on 177Lu-SPECT to PSMA-PET/CT at a minimum SUV cutoff of 3 [5].